¥Û¡¼¥à ¡ä°åÎÅ´Ø·¸¼Ô¤ÎÊý¤Ø ¡äÃø½ñ¡¦³Ø²ñ¡¦ÏÀʸ
Ãø½ñ¡¦³Ø²ñ¡¦ÏÀʸ
ÅöÈøÆ»Áí¹çɱ¡¡¢¤ª¤è¤Ó³Æ°å»Õ¤Ë¤è¤Ã¤Æȯɽ¤µ¤ì¤¿Ãø½ñ¡¢³Ø²ñ¤Ç¤ÎȯɽÏÀʸ¤Ê¤É¤ò¸ø³«¤·¤Æ¤¤¤Þ¤¹¡£

[ ½Û´Ä´ïÆâ²Ê ] ¤Ë¤è¤ëÃø½ñ¡¦³Ø²ñ¡¦ÏÀʸ
¡ÖÃø½ñ¡×¡Ö³Ø²ñ¡×¡ÖÏÀʸ¡×¤ÎʬÌî¤Ëʬ¤«¤ì¤Æ¤¤¤Þ¤¹¡£¤´´õ˾¤ÎʬÌî¤ò¥¯¥ê¥Ã¥¯¤¹¤ë¤È°ìÍ÷¤¬É½¼¨¤µ¤ì¤Þ¤¹¡£

¹¹¿·Æü¡§2025/02/21
¿ÇÎÅ²Ê | ½Û´Ä´ïÆâ²Ê |
ǯ | 2023 |
ÏÀʸ¥¿¥¤¥È¥ë | É·¿¿ÇÃǤ˶ìθ¤·¤¿¥¢¥ß¥í¥¤¥É¡¼¥·¥¹¤Î°ìÎã |
»¨»ï¥¿¥¤¥È¥ë | ¸üÀ¸Ï¢ÈøÆ»Áí¹çɱ¡°åÊó¡¤33 |
¥Ú¡¼¥¸ÈÖ¹æ | 13-16 |
Ãø¼Ô | Éð»Ô°ìµ± |
¶¦Ãø | ½ÅΤÐÒÊ㡤ÌÚ²¼¹°´î¡¤Âç°æË®¿Ã¡¤ÂçÄͲíÌ顤¿¹Åç¿®¹Ô |
¹¹¿·Æü¡§2023/12/29
¿ÇÎÅ²Ê | ½Û´Ä´ïÆâ²Ê |
ǯ | 2022 |
ÏÀʸ¥¿¥¤¥È¥ë | µÞÀ¿´¶Ú¹¼ºÉ¤ËÆÍȯÀ¿©Æ»ÇËÎö¤ò¹çÊ»¤·¤¿¤¬Îɹ¥¤Êžµ¡¤òé¤Ã¤¿£±Îã |
»¨»ï¥¿¥¤¥È¥ë | ¹Åç°å³Ø¡¡75(9) |
¥Ú¡¼¥¸ÈÖ¹æ | 403-407 |
Ãø¼Ô | Àж¶Ä¾¼ù |
¶¦Ãø | Ô¢Åıѻʡ¤»³º¬¡¡ºÌ¡¤±Ê°æÆ»ÌÀ¡¤¹áÀî±Ñ²ð¡¤¾®ÅÄ¡¡ÅС¤²ÃÆ£²íÌ顤ÀÄÌÚµÁϯ¡¤ÅÚ¼ê·Ä¸Þ¡¥ |
¹¹¿·Æü¡§2023/12/29
¿ÇÎÅ²Ê | ½Û´Ä´ïÆâ²Ê |
ǯ | 2022 |
ÏÀʸ¥¿¥¤¥È¥ë | ·ò¹¯¿ÇÃǤÎCT¤ò·Àµ¡¤Ëȯ¸«¤µ¤ì¤¿º¸Æâ·ÐÆ°Ì®ÇÙÆ°Ì®áñ¤Î°ìÎã |
»¨»ï¥¿¥¤¥È¥ë | ¸üÀ¸Ï¢ÈøÆ»Áí¹çɱ¡°åÊó¡¡32 |
¥Ú¡¼¥¸ÈÖ¹æ | ¡ü11-14 |
Ãø¼Ô | Àж¶Ä¾¼ù |
¶¦Ãø | ÂçÄͲíÌ顤Åìµ·¾ô¹§¡¤ÌÖ²¬Æ»¹§¡¤ÌÚ²¼¹°´î¡¤»³ÌÚ¡¡¼Â¡¤º´Æ£¹îÉÒ¡¤¿¹Åç¿®¹Ô¡¥ |
¹¹¿·Æü¡§2023/12/29
¿ÇÎÅ²Ê | ½Û´Ä´ïÆâ²Ê |
ǯ | 2023 |
ÏÀʸ¥¿¥¤¥È¥ë | Impact of SGLT2 inhibitors on old age patients with heart failure and chronic kidney disease¡¥ |
»¨»ï¥¿¥¤¥È¥ë | Int J Cardiol¡¥370 |
¥Ú¡¼¥¸ÈÖ¹æ | 294-299 |
Ãø¼Ô | Amioka M |
¶¦Ãø | Sanada R¡¤Matsumura H¡¤Kinoshita H¡¤Sairaku A¡¤Morishima N¡¤Nakano Y¡¥ |
¹¹¿·Æü¡§2023/04/28
¿ÇÎÅ²Ê | ½Û´Ä´ïÆâ²Ê |
ǯ | 2021 |
ÏÀʸ¥¿¥¤¥È¥ë | Does atrial fibrillation ablation worsen preexisting anemia? Another anemia paradox in DOAC era |
»¨»ï¥¿¥¤¥È¥ë | Journal of Cardiology¡¥78¡Ê5¡Ë |
¥Ú¡¼¥¸ÈÖ¹æ | 382¡Ý387 |
Ãø¼Ô | Sairaku A |
¶¦Ãø | Morishima N¡¤Amioka M¡¤¡ÊMaeda J¡Ë¡¤¡ÊWatanabe Y¡Ë¡¤¡ÊNakano Y¡Ë |
¹¹¿·Æü¡§2022/05/24
¿ÇÎÅ²Ê | ½Û´Ä´ïÆâ²Ê |
ǯ | 2020 |
ÏÀʸ¥¿¥¤¥È¥ë | Prognostic significance of oscillatory ventilation at rest in patients with advanced heart failure undergoing cardiopulmonary exercise testing |
»¨»ï¥¿¥¤¥È¥ë | Int J Cardiol¡¥301 |
¥Ú¡¼¥¸ÈÖ¹æ | 142¡Ý146 |
Ãø¼Ô | Kinoshita H |
¶¦Ãø | Sairaku A¡¤Morishima N¡¤¡ÊDohi Y¡Ë¡¤¡ÊSada Y¡Ë¡¤¡ÊHigashi A¡Ë¡¤¡ÊYamabe S¡Ë¡¤¡ÊKihara Y¡Ë |
¹¹¿·Æü¡§2022/05/24
¿ÇÎÅ²Ê | ½Û´Ä´ïÆâ²Ê |
ǯ | 2020 |
ÏÀʸ¥¿¥¤¥È¥ë | Intra-procedural anticoagulation and post-procedural hemoglobin fall in atrial fibrillation ablation with minimally interrupted direct oral anticoagulants: comparisons across 4 drugs. |
»¨»ï¥¿¥¤¥È¥ë | J Interv Card Electrophysiol¡¥doi: 10 |
¥Ú¡¼¥¸ÈÖ¹æ | 1007/s10840-020-00851-6 |
Ãø¼Ô | Sairaku A |
¶¦Ãø | Morishima N¡¤Matsumura H¡¤Amioka M¡¤Maeda J¡¤¡ÊWatanabe Y¡Ë¡¤¡ÊNakano Y¡Ë |
¹¹¿·Æü¡§2021/11/25
¿ÇÎÅ²Ê | ½Û´Ä´ïÆâ²Ê |
ǯ | 2019 |
ÏÀʸ¥¿¥¤¥È¥ë | A mimic of tachycardia-bradycardia syndrome in a patient with long-standing persistent atrial fibrillation¡¥ |
»¨»ï¥¿¥¤¥È¥ë | Clin Case Rep.¡¡7¡Ê4¡Ë |
¥Ú¡¼¥¸ÈÖ¹æ | 661¡Ý664 |
Ãø¼Ô | ¡Ê Akinori Sairaku¡Ë |
¶¦Ãø | ¡ÊTakeshi Matsumoto¡Ë¡¤Hiroki Kinoshita¡¤Hiroya Matsumura¡¤Naoto Oguri¡¤Nobuyuki Morishima |
¹¹¿·Æü¡§2021/11/25
¿ÇÎÅ²Ê | ½Û´Ä´ïÆâ²Ê |
ǯ | 2019 |
ÏÀʸ¥¿¥¤¥È¥ë | Prognostic significance of oscillatory ventilation at rest in patients with advanced heart Failure undergoing cardiopulmonary exercise testing |
»¨»ï¥¿¥¤¥È¥ë | Int J Cardiol¡¡301 |
¥Ú¡¼¥¸ÈÖ¹æ | 142-146 |
Ãø¼Ô | Hiroki Kinoshita |
¶¦Ãø | Akinori Sairaku¡¤Nobuyuki Morishima¡¤¡ÊYoshihiro Dohi¡Ë¡¤¡ÊYoshiharu Sada¡Ë¡¤¡Ê Akifumi Higashi¡Ë¡¤¡ÊSayuri Yamabe¡Ë¡¤¡ÊYasuki Kihara¡Ë |
¹¹¿·Æü¡§2021/02/19
¿ÇÎÅ²Ê | ½Û´Ä´ï²Ê |
ǯ | 2020 |
¥¿¥¤¥È¥ë | Intra-procedural anticoagulation and post-procedural hemoglobin fall in atrial fibrillation ablation with minimally interrupted directoral anticoagulants:comparisons across 4 drugs |
»¨»ï̾ | Journal of Interventional Cardiac Electrophysiology |
Ãø¼Ô | Akinori Sairaku¡¢Nobuyuki Morishima¡¢Hiroya Matsumura¡¢Michitaka Amioka¡¢Junji Maeda |
¹¹¿·Æü¡§2020/06/18
¿ÇÎÅ²Ê | ½Û´Ä´ï²Ê |
ǯ | 2020 |
ÏÀʸ¥¿¥¤¥È¥ë | Prognostic significance of oscillatory ventilation at rest in patients with advanced heart failure undergoing cardiopulmonary exercise testing. |
»¨»ï¥¿¥¤¥È¥ë | Int J Cardiol. |
¥Ú¡¼¥¸ÈÖ¹æ | 142-146 |
Ãø¼Ô | Kinoshita H |
¶¦Ãø | Sairaku A, Morishima N, Dohi Y, Sada Y, Higashi A, Yamabe S, Kihara Y. |
¹¹¿·Æü¡§2020/06/17
¿ÇÎÅ²Ê | ½Û´Ä´ïÆâ²Ê |
ǯ | 2019 |
ÏÀʸ¥¿¥¤¥È¥ë | A mimic of tachycardia-bradycardia syndrome in a patient with long-standing persistent atrial fibrillation. |
»¨»ï¥¿¥¤¥È¥ë | Clin Case Rep.¡¡7¡Ê4¡Ë |
¥Ú¡¼¥¸ÈÖ¹æ | 661-664 |
Ãø¼Ô | Sairaku A |
¶¦Ãø | Matsumoto T¡¤Kinoshita H¡¤Matsumura H¡¤Oguri N¡¤Morishima N |
¹¹¿·Æü¡§2020/06/17
¿ÇÎÅ²Ê | ½Û´Ä´ïÆâ²Ê |
ǯ | 2018 |
ÏÀʸ¥¿¥¤¥È¥ë | Increased Urinary Liver-Type Fatty Acid-Binding Protein Level Predicts Worsening Renal Function in Patients With Acute Heart Failure |
»¨»ï¥¿¥¤¥È¥ë | J Card Fail 24¡Ê8¡Ë |
¥Ú¡¼¥¸ÈÖ¹æ | 520-524 |
Ãø¼Ô | Okubo Y |
¶¦Ãø | Sairaku A¡¤Morishima N¡¤¡ÊOgi H¡Ë¡¤Matsumoto T¡¤Kinoshita H¡¤¡ÊKihara Y¡Ë |
¹¹¿·Æü¡§2020/06/17
¿ÇÎÅ²Ê | ½Û´Ä´ï²Ê |
ǯ | 2019 |
ÏÀʸ¥¿¥¤¥È¥ë | A mimic of tachycardia-bradycardia syndrome in a patient with long-standing persistent atrial fibrillation. |
»¨»ï¥¿¥¤¥È¥ë | Clin Case Rep. |
¥Ú¡¼¥¸ÈÖ¹æ | 661-664 |
Ãø¼Ô | Sairaku A |
¶¦Ãø | Matsumoto T, Kinoshita H, Matsumura H, Oguri N, Morishima N. |
¹¹¿·Æü¡§2020/06/16
¿ÇÎÅ²Ê | ½Û´Ä´ï²Ê |
ǯ | 2018 |
ÏÀʸ¥¿¥¤¥È¥ë | Increased Urinary Liver-Type Fatty Acid-Binding Protein Level Predicts Worsening Renal Function in Patients With Acute Heart Failure. |
»¨»ï¥¿¥¤¥È¥ë | J Card Fail. |
¥Ú¡¼¥¸ÈÖ¹æ | 520-524 |
Ãø¼Ô | Okubo Y |
¶¦Ãø | Sairaku A, Morishima N, Ogi H, Matsumoto T, Kinoshita H, Kihara Y. |
¹¹¿·Æü¡§2015/02/01
¿ÇÎÅ²Ê | ½Û´Ä´ï²Ê |
ǯ | 2013 |
ÏÀʸ¥¿¥¤¥È¥ë | ¡¡V1¡Ý2 ͶƳ¤ÇST ¾å¾º¤òǧ¤á¤¿µÞÀ²¼ÊÉ¿´¶Ú¹¼ºÉ¤Î£±Îã |
»¨»ï¥¿¥¤¥È¥ë | ¹Åç°å³Ø¡¡66 |
¥Ú¡¼¥¸ÈÖ¹æ | 628¡Ý631 |
Ãø¼Ô | ÀîºêÀµ·û |
¶¦Ãø | ¾åÅÄ·òÂÀϺ¡¤ËåÈø½ß¹°¡¤¡ÊÅÏî´µª¾½¡Ë¡¤ÈøÌÚ¡¡¹À¡¤¿¹Åç¿®¹Ô |
¹¹¿·Æü¡§2015/02/01
¿ÇÎÅ²Ê | ½Û´Ä´ï²Ê |
ǯ | 2013 |
ÏÀʸ¥¿¥¤¥È¥ë | ÅDz¼·ì¤ò¼çÁʤËÍ象¤·¤¿Ê¢ÉôÂçÆ°Ì®áî½Ñ¸å¤Î£±Îã |
»¨»ï¥¿¥¤¥È¥ë | ¹Åç°å³Ø¡¡66 |
¥Ú¡¼¥¸ÈÖ¹æ | 266¡Ý269 |
Ãø¼Ô | ¡ÊÅÏî´µª¾½¡Ë |
¶¦Ãø | ¾åÅÄ·òÂÀϺ¡¤ËåÈø½ß¹°¡¤ÈøÌÚ¡¡¹À¡¤¿¹Åç¿®¹Ô¡¤¡ÊÆó¿ÀÂç²ð¡Ë¡¤¡ÊßÀËÜÀµ¼ù¡Ë |
¹¹¿·Æü¡§2012/05/01
¿ÇÎÅ²Ê | ½Û´Ä´ï²Ê |
ǯÅÙ | 2012 |
ÏÀʸ¥¿¥¤¥È¥ë | º¸Á°²¼¹Ô»ÞËýÀÊĺÉÉÂÊѤËÂФ·Ãæ³Ö»Þ¤ò·Ðͳ¤¹¤ë¦Éû·ì¹ÔÏ©¤ò²ð¤·¤¿Æ±Â¦µÕ¹ÔÀ¥¢¥×¥í¡¼¥Á¤Ë¤ÆºÆ³«Ä̤ËÀ®¸ù¤·¤¿°ìÎã |
»¨»ï¥¿¥¤¥È¥ë | CVIT Jpn Ed 4 |
¥Ú¡¼¥¸ÈÖ¹æ | 48-52 |
Ãø½ñ | ÅÏî´µª¾½ |
¶¦Ãø | ¡Ê±ö½ÐÀëͺ¡Ë¡¤¡ÊÀµ²¬²Â»Ò¡Ë¡¤¡Ê¼²¬Íµ»Ê¡Ë¡¤¡ÊËÊ¡¡¡¼é¡Ë¡¤¡Ê²ËÜÃÒÏ¡ˡ¤¡ÊÂçÄͲíÌé¡Ë¡¤¡Ê°ÙÀ¶ÇîÆ»¡Ë¡¤¡Ê»°¸Í¿¹»ù¡Ë¡¤¡ÊÀîÀ¥¶¦¼£¡Ë¡¤¡Ê¹áÀîͺ»°¡Ë¡¤ËåÈø½ß¹°¡¤¡ÊÎÓ¡¡¹¯É§¡Ë |
¹¹¿·Æü¡§2011/05/01
¿ÇÎÅ²Ê | ½Û´Ä´ï²Ê |
ǯÅÙ | 2011 |
ÏÀʸ¥¿¥¤¥È¥ë | A case of adult ductus arteriosus with congestive heart failure and severe mitral regurgitation. |
»¨»ï¥¿¥¤¥È¥ë | Cardiovasc Interv and Ther 26 |
¥Ú¡¼¥¸ÈÖ¹æ | 278-280 |
Ãø½ñ | Watanabe N |
¶¦Ãø | ¡ÊToyofuku M¡Ë¡¤¡ÊHayashi Y¡Ë¡¥ |
- ¾Ã²½´ïÆâ²Ê
- ½Û´Ä´ïÆâ²Ê
- ¸ÆµÛ´ïÆâ²Ê
- ¿Õ¡Æâ²Ê
- ¾®»ù²Ê
- Æâ»ë¶À³°²Ê
- ¿´Â¡·ì´É³°²Ê
- ¸ÆµÛ´ï³°²Ê
- À°·Á³°²Ê
- Ǿ¿À·Ð³°²Ê
- ÈéÉæ²Ê
- ÈçÇ¢´ï²Ê
- ¼ªÉ¡°ö¹¢²Ê
- Ëã¿ì²Ê
- ´ã²Ê
- »ºÉؿͲÊ
- Êü¼ÍÀþ²Ê
- µßµÞ²Ê
- Áí¹ç¿ÇÎŲÊ
- »õ²Ê¸ý¹Ð³°²Ê
- ´ËÏÂ¥±¥¢Æâ²Ê
- Àº¿À¿À·Ð²Ê
- ¾®»ù³°²Ê
- ´ËÏÂ¥±¥¢³°Íè
- Î×¾²¸¦½¤²Ê
- ÉÂÍý¸¦µæ¸¡ºº²Ê
- °å»ö²Ý
- ¾ðÊó´ë²è²Ý
- ²½³ØÎÅË¡¥»¥ó¥¿¡¼
- °åÎÅÊ¡»ã»Ù±ç¥»¥ó¥¿¡¼
- ±ÉÍÜ¥µ¥Ý¡¼¥È¥Á¡¼¥à¡ÊNST¡Ë
- ÌôºÞ²Ê
- ´Ç¸î²Ê
- Êü¼ÍÀþ²Ê(°åÎŵ»½ÑÉôÌç)
- Î×¾²¹©³Ø²Ê
- ¥ê¥Ï¥Ó¥ê¥Æ¡¼¥·¥ç¥ó²Ê
- Î×¾²¸¦µæ¸¡ºº²Ê
- ±ÉÍܲÊ
´Ç¸î²Ê¤Î¤´°ÆÆâ
- ´Ç¸î²Ê¥Ú¡¼¥¸TOP ÈøÆ»Áí¹çɱ¡´Ç¸î²Ê¤Ç¤Î³èÆ°ÆâÍƤȤ´Êó¹ð¤Ç¤¹¡£ÀìÌç³Ø¹»¾ðÊó¤Ê¤É¡£
¤¬¤ó¿ÇÎÅÏ¢·ÈµòÅÀɱ¡
- ÈøÆ»Áí¹çɱ¡¤¬¤ó¾ðÊó ¤¬¤ó¤Ë¤Ä¤¤¤Æ¤ÎÀâÌÀ¤ä¥Ç¡¼¥¿Åù¡¢¤¬¤ó¤Ë¤Ä¤¤¤Æ¤Î¾ðÊó¤Ç¤¹¡£
¤¬¤ó¿ÇÎÅÏ¢·ÈµòÅÀɱ¡
- 繤¬¤ó¥×¥í¥¸¥§¥¯¥È ¤¹¤¤Â¡¡¦´Î¡¤¬¤ó¶µ¼¼¤Î»ñÎÁ
